equities31m
Michael McTague: In 2025, the pharmaceutical industry is ripe for M&A
Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...
Contract Pharma9d
The Evolution of Strategic Partnerships in the Pharmaceutical Industry
The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...
Reuters27d
Royalty Pharma simplifies corporate structure with $1.1 bln deal
Royalty Pharma said its decision follows feedback from investors that the current structure made it difficult to invest in the healthcare firm, and shifting to an internal management could enhance ...
Astellas Makes Announcement about Management Structure
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the following changes to its management structure effective April 1, 2025.
AOL27d
Royalty Pharma simplifies corporate structure with $1.1 billion deal
Royalty Pharma said its decision follows feedback from investors that the current structure made it difficult to invest in the healthcare firm, and shifting to an internal management could enhance ...